The Lancet had an update on the Oxford phase 2 results. It seems promising. We should get early phase 3 results before the years end. This will be much easier to mass distribute if it's effective. Takes two shots and time
Quote:
Two weeks after the second dose, more than 99% of participants had neutralising antibody responses. These included people of all ages.
The T-cell response - another measure of how well the immune system responds - peaked two weeks after the first dose of the vaccine, regardless of age.
|